T. Rowe Price Associates’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-5,451,998
| Closed | -$67.8M | – | 2633 |
|
2016
Q4 | $67.8M | Sell |
5,451,998
-567,990
| -9% | -$7.07M | 0.01% | 709 |
|
2016
Q3 | $82.4M | Buy |
6,019,988
+5,945,688
| +8,002% | +$81.4M | 0.02% | 632 |
|
2016
Q2 | $549K | Hold |
74,300
| – | – | ﹤0.01% | 1925 |
|
2016
Q1 | $475K | Buy |
74,300
+11,900
| +19% | +$76.1K | ﹤0.01% | 1993 |
|
2015
Q4 | $390K | Buy |
62,400
+400
| +0.6% | +$2.5K | ﹤0.01% | 2061 |
|
2015
Q3 | $362K | Hold |
62,000
| – | – | ﹤0.01% | 2077 |
|
2015
Q2 | $513K | Hold |
62,000
| – | – | ﹤0.01% | 1986 |
|
2015
Q1 | $511K | Buy |
62,000
+14,500
| +31% | +$120K | ﹤0.01% | 1962 |
|
2014
Q4 | $326K | Hold |
47,500
| – | – | ﹤0.01% | 2137 |
|
2014
Q3 | $257K | Hold |
47,500
| – | – | ﹤0.01% | 2220 |
|
2014
Q2 | $303K | Hold |
47,500
| – | – | ﹤0.01% | 2174 |
|
2014
Q1 | $383K | Hold |
47,500
| – | – | ﹤0.01% | 2030 |
|
2013
Q4 | $324K | Sell |
47,500
-469,500
| -91% | -$3.2M | ﹤0.01% | 2106 |
|
2013
Q3 | $9.51M | Sell |
517,000
-758,250
| -59% | -$14M | ﹤0.01% | 1282 |
|
2013
Q2 | $22.3M | Buy |
+1,275,250
| New | +$22.3M | 0.01% | 1037 |
|